The Defense Threat Reduction Agency (DTRA) of the U.S. Department of Defense (DoD) announced IAVI has been awarded $35.7 million dollars to develop a recombinant vesicular stomatitis virus (VSV) vector Marburg virus candidate, called rVSVΔG-MARV-GP. IAVI licensed...